Politics

Politics By Nicholas Florko

In its search for a new FDA commissioner, the White House is relying on insiders for advice

Politics By Lev Facher

Francis Collins’ resignation could complicate the fight over funding for ARPA-H

Politics By Lev Facher

Here’s who might replace Francis Collins as NIH director

Politics By Lev Facher

NIH Director Francis Collins to step down

Politics By Rachel Cohrs

Biden administration favors insurers over doctors, hospitals in controversial new surprise billing regulations

Exclusive By Rachel Cohrs and Nicholas Florko

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Politics By Nicholas Florko

The government’s Covid-19 response will continue in a shutdown, but health agencies will face major staff shortages

Politics By Rachel Cohrs

Big business lobbies bitterly divided over drug pricing reform

Politics By Rachel Cohrs and Nicholas Florko

In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking

Politics By Lev Facher and Helen Branswell

Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers

Exclusive By Rachel Cohrs

Senate proposes expanding pharma penalties for hiking drug prices

Politics By Nicholas Florko and Rachel Cohrs

‘A solid black eye’: Drug pricing reform advocates scramble to reset after setback in Congress

Politics By Nicholas Florko

Drug makers failed to block House provision cracking down on orphan drug tax credits

Politics By Rachel Cohrs

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Politics By Rachel Cohrs

Virtual Event: The 340B drug discount program is at a crossroads. What’s next?

Politics By Nicholas Florko and Rachel Cohrs

Key senator opposes Democrats’ target for drug pricing savings

Politics By Rachel Cohrs

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

Politics By Rachel Cohrs

Biden administration releases $25 billion in Covid relief for providers after months of delay

Politics By Nicholas Florko

FDA misses deadline for deciding which e-cigarette products should be removed from the market

Exclusive By Nicholas Florko and Rachel Cohrs

Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates

Politics By Nicholas Florko

The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?

Politics By Rachel Cohrs

Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?

Health By Lev Facher

The White House wants $65 billion for an ‘Apollo’-style pandemic preparedness program

Politics By Rachel Cohrs

Congress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug

Politics By Rachel Cohrs

The 10 power players to watch on Democrats’ drug pricing push

Politics By Lev Facher

Biden pledged to ‘follow the science.’ But experts say he’s sometimes fallen short

Politics By Nicholas Florko

How one vape shop is openly defying FDA regulations

Politics By Nicholas Florko and Lev Facher

Two top FDA officials in charge of Covid-19 vaccines to leave agency this fall

Exclusive By Nicholas Florko

‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby